No Record Found
Sector
PharmaceuticalsOpen
₹34.55Prev. Close
₹34.38Turnover(Lac.)
₹0.17Day's High
₹34.55Day's Low
₹33.1252 Week's High
₹63.5952 Week's Low
₹31.3Book Value
₹38.66Face Value
₹10Mkt Cap (₹ Cr.)
33.99P/E
13.12EPS
2.62Divi. Yield
0No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | 
|---|---|---|---|---|
| Equity Capital | 10 | 10 | 10 | 3.25 | 
| Preference Capital | 0 | 0 | 0 | 0 | 
| Reserves | 28.66 | 26.1 | 24.3 | 4.4 | 
| Net Worth | 38.66 | 36.1 | 34.3 | 7.65 | 
| Minority Interest | 
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2016 | Mar-2015 | 
|---|---|---|---|---|
| Revenue | 41.02 | 46.93 | 0 | 0.27 | 
| yoy growth (%) | -12.59 | 0 | -100 | |
| Raw materials | -35.78 | -41.94 | 0 | -0.13 | 
| As % of sales | 87.22 | 89.37 | 0 | 49.48 | 
| Employee costs | -0.85 | -0.98 | 0 | 0 | 
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2016 | Mar-2015 | 
|---|---|---|---|---|
| Profit before tax | 1.66 | 1.53 | 0 | 0 | 
| Depreciation | -0.06 | -0.02 | 0 | 0 | 
| Tax paid | -0.46 | -0.41 | 0 | 0 | 
| Working capital | -3.46 | 6.57 | 0.12 | |
| Other operating items | 
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2016 | Mar-2015 | 
|---|---|---|---|---|
| Growth matrix (%) | ||||
| Revenue growth | -12.59 | 0 | -100 | |
| Op profit growth | 6.66 | 0 | -100 | |
| EBIT growth | 11.31 | 0 | -100 | |
| Net profit growth | 6.84 | 0 | -100 | 
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | 
|---|---|---|---|---|---|
| Gross Sales | 95.32 | 71.36 | 76.23 | 74.26 | 69.74 | 
| Excise Duty | 0 | 0 | 0 | 0 | 0 | 
| Net Sales | 95.32 | 71.36 | 76.23 | 74.26 | 69.74 | 
| Other Operating Income | 0 | 0 | 0 | 0 | 0 | 
| Other Income | 0.52 | 0.4 | 0.51 | 0.31 | 0.18 | 
| Company Name | LTP (₹) | P/E  (%) | Mkt.Cap  (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield  (%) | Sales Qtr  (₹.Cr) | Book Value (₹) | 
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,703.6 | 82.06 | 4,08,750.71 | 753.53 | 0.94 | 5,566.68 | 101.44 | 
| Divis Laboratories Ltd DIVISLAB | 6,653.65 | 75.61 | 1,76,633.5 | 557 | 0.45 | 2,357 | 561.08 | 
| Cipla Ltd CIPLA | 1,540.5 | 23.94 | 1,24,437.16 | 1,210.53 | 1.04 | 4,495.16 | 411.56 | 
| Torrent Pharmaceuticals Ltd TORNTPHARM | 3,600.9 | 61.3 | 1,21,865.35 | 551 | 0.17 | 2,567 | 224.34 | 
| Mankind Pharma Ltd MANKIND | 2,445.75 | 55.79 | 1,00,950.41 | 412.76 | 0 | 2,541.36 | 354.69 | 
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director
Samir Shah
Chairperson
Tanvi Shah
Independent Director
Ankur Amiram Dave
Independent Director
Priyank Lalitbhai Sancheti
Independent Director
Parshwa Kaushal Shah
Non Executive Director
Swati J Shah.
213 2nd Floor,
Raheja Chambers Nariman Point,
Maharashtra - 400021
Tel: -
Website: http://www.medicointercontinental.com
Email: mail@medicointercontinental.com
9 ShivShakti Indl Es,
J R Boricha Marg, Lower Parel,
Mumbai - 400 011
Tel: 91-22-23016761/8261
Website: -
Email: -
Summary
Medico Intercontinental Limited (Formerly known as Intercontinental Leasing & Finance Company Limited) was incorporated on August 14, 1984 in Ahmedabad, India. The Company changed its name to Medico I...
Read More
Reports by Medico Intercontinental Ltd








 IIFL Customer Care Number
 IIFL Customer Care Number 
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000  / 7039-050-000
 IIFL Capital Services Support WhatsApp Number
 IIFL Capital Services Support WhatsApp Number
+91 9892691696


IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.